Novozymes acquires enzyme business from Canadian Iogen Corporation
date:Feb 04, 2013
industries. The company has close to 70 employees and sells more than 20 products globally.

Iogen Bio-Products is a good fit for Novozymes, says Andrew Fordyce, Vice President of Global Enzyme Sales and Customer Solutions at Novozymes. We get a number of products that complement our existing product portfolio and welcome a talented group of employees who are very good at developing and producing industrial enzymes.

The acquisition is expected to have a positive impact on Novozymes sales growt
2/4 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
07/10 21:50